Marko Andabaka

In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with Fingolimod

Eugenio Cavalli, Emanuela Mazzon, Maria Sofia Basile et al. · Molecules · 2019 · 32 citations · Full text

Life Sciences, Immunology, Neurology +17

The prevalence of comorbidities in patients with multiple sclerosis: population-based registry data

Gorica Marić, Tatjana Pekmezović, Olivera Tamaš et al. · Neurological Sciences · 2020 · 30 citations

Medicine, Neurology, Clinical Epidemiology +12

Autonomic dysfunction in people with neuromyelitis optica spectrum disorders

Luka Crnošija, Magdalena Krbot Skorić, Marko Andabaka et al. · Multiple Sclerosis Journal · 2019 · 22 citations

Life Sciences, Neurology, Neuroscience +17

COVID-19 and vaccination against SARS-CoV-2 in patients with neuromyelitis optica spectrum disorders

Vanja Jovičević, Jovana Ivanović, Marko Andabaka et al. · Multiple Sclerosis and Related Disorders · 2021 · 15 citations · Full text

Veterinary Medicine, Infectious Diseases, Neurology +11

Aquaporin4-IgG seropositivity significantly increases the risk of comorbid autoimmune diseases in NMOSD patients: population-based registry data

Tatjana Pekmezović, Vanja Jovičević, Marko Andabaka et al. · Journal of Neurology · 2024 · 12 citations

Life Sciences, Immunology, Autoimmunity +13